We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

First Endocervical Tissue Sampler for Cervical Cancer Diagnosis Captures Comprehensive 360-Degree Sample

By HospiMedica International staff writers
Posted on 04 May 2023
Print article
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)
Image: FemCerv is the first and only approach for comprehensive tissue sampling for diagnosis of cervical cancer (Photo courtesy of Femasys)

There is a pressing need for advancements in the current standard of care for diagnosing the presence of cancerous cells in a woman's cervix. When a woman's pap smear yields abnormal results, she usually undergoes a colposcopy, which often involves endocervical curettage or obtaining a tissue sample from the highly sensitive cervical canal. The available tools for collecting this tissue are limited and can cause pain, bleeding, and severe discomfort, as well as produce inadequate or contaminated samples. If sample contamination occurs, additional tests and office visits would be needed to acquire more samples. Now, the first-ever endocervical tissue sampler (curette) designed to collect and secure a comprehensive sample, maximizing quality and quantity, brings much-needed advanced technologies to women.

Femasys Inc.’s (Suwanee, GA, USA) FemCerv, an FDA-cleared endocervical sampler, is the first of its kind, designed to capture a complete and uncontaminated sample through a relatively pain-free procedure. FemCerv features an expandable collection chamber that is exposed during sampling and closed during removal to contain cervical cells and tissue. It can be used alongside colposcopy and aims to capture and preserve a comprehensive 360-degree tissue sample in a relatively pain-free office visit. FemCerv has now also received approval from Health Canada, the Public Health Agency of Canada.

“We are delighted to gain another product approval in Canada, with FemCerv now available to women throughout all of North America as a more advanced alternative for tissue sampling to detect cervical cancer,” said Kathy Lee-Sepsick, Femasys’ founder, president and, chief executive officer.

Related Links:
Femasys Inc. 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Orthopedic Extension
AMSCO

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.